Academic Title: Assistant Professor

Degree: PhD

General Specialization: Pharmacology and Therapeutics

Subspecialty: Pharmacology and Therapeutics

Country of last degree: Iraq

Date of last degree: 2019

Subjects Taught:

Medications

Therapies

Pharmacoeconomics

Community Health

Hospital Training

Number of participations in scientific discussions (Master's/PhD): Three.

• Ibudilast and Octreotide both Ameliorate Acute Pancreatitis via Down-Regulation of the Inflammatory Cytokines and Toll-Like Receptor 4 - International Journal of Pharmaceutical Research, 2019.

• Ibudilast and Octreotide Ameliorate Acute Pancreatitis by Down Regulation of the Inflammatory and Oxidative Pathways - International Journal of Pharmaceutical Research, 2019.

• Ibudilast and Octreotide can ameliorate acute pancreatitis via down-regulation of the inflammatory cytokines and Nuclear Factor- Kappa B expression - Annals of Tropical Medicine & Public Health, 2019.

• Ibudilast Ameliorates Acute Pancreatitis through Downregulation of Interleukin-1 Beta and Lipase Enzyme - Asian Journal of Pharmaceutics, 2020.

• The impact of atorvastatin reload in patients undergoing percutaneous coronary intervention and its correlation with the toll-like receptors - Systemic Review in Pharmacy, 2019.

• Diastolic function assessment in hypertensive patients - Texas Journal of Medical Science, 2022.

• Global longitudinal strain in hypertensive patients with low exercise capacity - Texas Journal of Medical Science, 2022.

Medicines

Therapies

Pharmaceutical Economics

Community Health

Hospital Training